CTOs on the Move

Impartner

www.impartner.com

 
Founded in 1997 by cloud visionary Craig Flynn, Impartner was acquired in 2015 by Kennet Partners and current CEO Joe Wang. Our team is driven by a passion for indirect channels, having seen firsthand what a powerful source of revenue they can be at companies such as Intel, LANDESK, EMC, Akamai, FusionIO, WatchGuard, and many more. Impartner is broadly recognized as the leader in the Channel Enablement category, mostly because our team of development wizards pack our solution with the tools necessary to transform your indirect channel from a boat anchor into your company`s most strategic asset.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.impartner.com
  • 10619 South Jordan Gateway Suite 130
    South Jordan, UT USA 84095
  • Phone: 801.501.7000

Executives

Name Title Contact Details
Tom Mayfield
Vice President of Engineering Profile
Kory Willis
Senior Director of Information Security Profile

Funding

Impartner raised $15M on 07/17/2017
Impartner raised $20M on 11/14/2019

Similar Companies

The CE Shop

The CE Shop specializes in online real estate education. Products offered include Pre-Licensing, Post-Licensing, Exam Prep, & Continuing Education.

wit inc

wit inc is a Salt Lake City, UT-based company in the Software and Internet sector.

FrontRunnerHC

If you are looking for a seamless solution for all your patients needs, you have come to the right place. Whether it is Insurance Verification, Eligibility, Advanced Eligibility, Credit Balances, FrontRunnerHC has exactly what you are looking for

Meebo

Meebo integrates all social networks and communications channels into a single, simple-to-use solution, and enables people to easily share content and communicate in real time with the people who matter to them.

ClinCapture

ClinCapture is the only validated electronic data capture software available to sponsors and CROs for free. As a leading cloud-based eClinical application, ClinCapture empowers its customers to build their own studies, lower their clinical trials costs...